Skip to main content
See every side of every news story
Published loading...Updated

New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy

Summary by Sci Tech Daily
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among people with obesity. A new clinical trial has found that tirzepatide, sold under the name Zepbound, led to significantly greater weight loss in people with obesity compared to semaglutide, known as Wegovy. Both are injectable medications designed to [...]

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

t-online broke the news in Berlin, Germany on Saturday, May 31, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal